91±¬ÁÏ

November 21

Daily pill slashes 'bad' cholesterol levels by 60% in yearlong trial

A new daily pill reduced bad cholesterol by 60% in a groundbreaking study of 303 adults with a genetic condition, offering hope for heart disease prevention.

November 20

Missouri attorney general takes new legal aim at mail-order abortion pills over safety concerns

Missouri attorney general sues FDA over generic mifepristone approval, alleging safety concerns and hospital complications from mail-order abortion pills.

November 17

Fast-growing cancer could be slowed by common blood pressure drug, research shows

Scientists accidentally discovered how an old blood pressure drug hydralazine could fight aggressive brain cancer by targeting cellular oxygen sensors.

November 15

Popular diabetes drug could block exercise benefits, new study warns

New research reveals metformin may reduce exercise benefits for diabetes patients, affecting blood sugar control and fitness gains in unexpected ways.

November 14

GLP-1 weight-loss medications linked to improved cancer survival in certain patients

GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San Diego researchers found in a 6,800-patient study.

November 12

Some cancer patients could avoid surgery with innovative new therapy

Researchers say a new drug-delivery implant could help patients with hard-to-treat bladder cancer avoid losing their bladders — and stay cancer-free for years.

November 9

America’s fattest states revealed — and how Ozempic is changing the map

Insurance data reveals dramatic regional differences in Ozempic and Mounjaro usage, with obesity-heavy states prescribing GLP-1 medications at triple the rate of others.

November 4

New health warning issued over popular sleep aid millions take nightly

A new study reveals that melatonin supplements may increase heart failure risk by 90% in chronic insomnia patients, challenging assumptions about this popular sleep aid.

November 4

'Dilbert' creator's desperate plea shines spotlight on alternative prostate cancer drug

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven effectiveness in extending survival.

November 3

DR. MAKARY, DR OZ: People talk about lowering healthcare costs, but the Trump administration is doing it

FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug costs by removing extra clinical trial requirements.